Investitionsthese
Novo Holdings invests in life science and bio-sustainability solutions to improve human health and environmental sustainability, generating attractive long-term returns for the Novo Nordisk Foundation. The firm emphasizes responsible investing, societal impact, and diversified capital allocation across multiple asset classes.
Investitionsphase
All stages of development (early-stage to established companies)
Bevorzugte Reifephase für die erste Finanzierung.
Sektoren & Themen
Life science companies, equities, bonds, real estate, infrastructure, and private equity investments with a focus on long-term value creation and sustainability.
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Ticketgröße
€5.520.000 - €66.240.000
Standard-Finanzierungsbetrag pro Runde.
Outreach & Dossier-Analysen
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
